ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 55 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 1,518 | -43.0% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 2,665 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | +33.3% | 2,665 | +136.5% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 1,127 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | -40.0% | 1,127 | -15.6% | 0.00% | – |
| Q3 2017 | $5,000 | 0.0% | 1,335 | 0.0% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 1,335 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | -16.7% | 1,335 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | 0.0% | 1,335 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | +100.0% | 1,335 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 1,335 | -1.8% | 0.00% | – |
| Q4 2015 | $5,000 | – | 1,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $7,674,000 | 1.12% |
| Northeast Financial Consultants Inc | 732,265 | $1,061,000 | 0.36% |
| Family Management Corp | 10,424 | $15,000 | 0.01% |
| AJ WEALTH STRATEGIES, LLC | 15,000 | $22,000 | 0.01% |
| Poehling Capital Management, INC. | 3,302 | $5,000 | 0.00% |
| A.R.T. Advisors, LLC | 48,692 | $70,000 | 0.00% |
| Virtu Financial LLC | 34,383 | $50,000 | 0.00% |
| Founders Capital Management | 3,000 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,854 | $220,000 | 0.00% |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | 10,500 | $15,000 | 0.00% |